Literature DB >> 6981085

Anti-inflammatory action of dexamethasone in vitrectomy infusion fluid.

M Raichand, G A Peyman, H Schwartz, C Roe.   

Abstract

Vitrectomy and lensectomy were performed in rabbits with infusion fluid containing dexamethasone. No ocular toxicity was observed in eyes that received dexamethasone up to a concentration of 400 micrograms/ml. Utilizing sensitive radioimmunoassay techniques after surgery, we observed significant reduction in ocular albumin levels in eyes treated with dexamethasone when compared with control eyes in which dexamethasone was not used. However, there was no significant difference in immunoglobulin levels between eyes from both groups.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981085

Source DB:  PubMed          Journal:  Ophthalmic Surg        ISSN: 0022-023X


  3 in total

1.  Intravitreal dexamethasone following vitreous surgery.

Authors:  C L Paris; G A Peyman; C M Gremillion; K J Blinder
Journal:  Int Ophthalmol       Date:  1991-05       Impact factor: 2.031

2.  Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?

Authors:  R G Williams; S Chang; M R Comaratta; G Simoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Effects of intravitreal dexamethasone on concentration of intravitreal vancomycin in experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis.

Authors:  M A Smith; J A Sorenson; C Smith; M Miller; M Borenstein
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.